IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients.

Huan Xie Jing Zhang Ran Luo Yan Qi Yizhang Lin Changhao Han Xi Li Dongfeng Zeng

Published in: BMC immunology (2024)

Humoral immune response to SARS-CoV-2 infection was impaired in lymphoma patients partly due to anti-CD20 and ASCT treatment. COVID-19 vaccination may be more needed for these patients.

Keyphrases

end stage renal disease
immune response
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
inflammatory response
dendritic cells
combination therapy